TLDR:
- ThinkCyte secures $32 million in Series C funding round.
- New funds to support global expansion and further development of VisionSort technology.
ThinkCyte has successfully completed its Series C funding round, securing a total of $32 million. The amount includes an additional $15 million raised in the extension round, following equity financing acquired last November. Japan Green Investment Corp. led the extension round for Carbon Neutrality (JICN), KIRIN-GB Fund I L.P., and SMBC Venture Capital No. 7 Investment Limited Partnership. The company also obtained a loan from Japan Finance Corporation. The new funds will support ThinkCyte’s global expansion and the further development of its VisionSort technology. This investment round is crucial for ThinkCyte’s growth; it is expected to enable the company to advance its sorting solutions in the global market. The latest funding round brings ThinkCyte’s total capital raised to $91 million as it advances the global reach of its flagship product, VisionSort™. Since its launch in June 2023, VisionSort™ has gained traction among major biopharmaceutical companies and top academic institutions worldwide. The Series C extension, led by Japan Green Investment Corp. for Carbon Neutrality (JICN), KIRIN-GB Fund I L.P., and SMBC Venture Capital No. 7 Investment Limited Partnership, along with a loan from Japan Finance Corporation, will support the company’s production and manufacturing expansion. The new investment will facilitate the scaling up of VisionSort™ production and accelerate ThinkCyte’s global commercial efforts. With this financial boost, the company aims to enhance its technological capabilities and extend its market presence, strengthening its role in advancing life sciences. With the new funding, ThinkCyte plans to drive progress in single-cell analysis and sorting technologies. Founded in 2016, ThinkCyte operates from Tokyo, Japan, and Redwood City, California. The company specializes in developing scientific instruments that integrate diverse technologies to support life science research, diagnostics, and therapeutic development. VisionSort™, the world’s first AI-based, dual-mode fluorescence and morphometric cell sorting platform, exemplifies ThinkCyte’s innovative approach. The company collaborates with leading biopharmaceutical firms and research institutions to advance groundbreaking research. Japan Green Investment Corp. for Carbon Neutrality (JICN) was established to support Japan’s transition to a low-carbon economy and enhance environmental sustainability. The organization focuses on investing in technologies and projects that reduce greenhouse gas emissions and promote carbon neutrality. JICN’s investments target sectors such as renewable energy, energy efficiency, and green technology, aiming to accelerate Japan’s efforts towards achieving its carbon neutrality goals and advancing global environmental sustainability.
